fluorobenzenes has been researched along with Endometrial Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ashworth, A; Dedes, KJ; Geyer, FC; Lambros, MB; Lord, CJ; Mackay, A; Mendes-Pereira, AM; Natrajan, R; Reis-Filho, JS; Savage, K; Vatcheva, R; Wetterskog, D | 1 |
1 other study(ies) available for fluorobenzenes and Endometrial Neoplasms
Article | Year |
---|---|
PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors.
Topics: Carcinoma, Endometrioid; Cell Line, Tumor; DNA Mutational Analysis; Drug Resistance, Neoplasm; Endometrial Neoplasms; Enzyme Inhibitors; Female; Fluorobenzenes; Humans; In Situ Hybridization, Fluorescence; Phthalazines; Poly(ADP-ribose) Polymerase Inhibitors; PTEN Phosphohydrolase | 2010 |